Nephrodite Earns FDA’s First Breakthrough Device Designation for an Implantable Kidney Replacement System
Holly™ by Nephrodite becomes the first device to achieve the designation, marking a major regulatory milestone toward first-in-human cl...
Continuous dialysis implant wins FDA Breakthrough Device Designation
The FDA has granted Breakthrough Device Designation to Nephrodite’s Holly implantable continuous dialysis system.
In an exclus...